Real World Assessment of People Living With Chronic Hepatitis B in Australia

Recruiting Observational Study
Hepatitis B
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
Kirby Institute · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The REACH-B study establishes an observational cohort study of people living with chronic hepatitis B from a national network, including a diverse range of services, to characterise and monitor hepatitis B linkage to care and treatment requirements amongst this population.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. All individuals diagnosed with chronic hepatitis B in the participating study sites are eligible to be included (both newly diagnosed cases and those diagnosed in the past). 2. 16 years of age or older. 3. Attended the health service for HBV care within the prior 12 months fr…
Contacts

Jessica Carter

+61290654212

jcarter@kirby.unsw.edu.au

CONTACT

Amanda Erratt

+61293850882

aerratt@kirby.unsw.edu.au

CONTACT